funded by Tianjin Clinical Research Center:Construction of Tianjin Clinical Research Center for Blood Diseases(2016.4-2019.12)(15ZXLCSY00010);National Key Research and Development Program of China(2021YFC2500003).
To The Editor:The role of measurable residual disease(MRD)in prognosis and treatment in acute myeloid leukemia(AML)is evolving.Studies have demonstrated the correlation between MRD and risks of relapse in adult AML:pe...